Vitamin D deficiency exacerbates atypical antipsychotic-induced metabolic side effects in rats: Involvement of the INSIG/SREBP pathway

References

Page 1

	Year	Citations
Antipsychotic Dosing in Preclinical Models Is Often Unrepresentative of the Clinical Condition: A Suggested Solution Based on in Vivo Occupancy Shitij Kapur, Susan C. VanderSpek, Barbara A. Brownlee, Journal of Pharmacology and Experimental Therapeutics	2003	474
Vitamin D: beyond bone Sylvia Christakos, Martin Hewison, David G. Gardner, Annals of the New York Academy of Sciences NutritionImmunologyOsteoporosisInflammationTranslational Medicine	2013	284
Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and toll-like receptor activation Christian L. Roth, Clinton Elfers, Dianne P. Figlewicz, Hepatology	2011	281
Vitamin D deficiency in early life accelerates Type 1 diabetes in non-obese diabetic mice Annapaula Giulietti, Conny Gysemans, Katinka Stoffels, Diabetologia ObesityMetabolic SyndromeNutritionType 1Body Composition	2004	219
Clozapine and Olanzapine Are Associated With Food Craving and Binge Eating Michael Kluge, Andreas Schuld, Hubertus Himmerich, Journal of Clinical Psychopharmacology	2007	176
Oral administration of 1,25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus Julia B. Zella, Laura C. McCary, Hector F. DeLuca Archives of Biochemistry and Biophysics 1,25-Dihydroxyvitamin D3Insulin ManagementDiabetesPharmacologyNod Mice	2003	173
Vitamin D protects against diet-induced obesity by enhancing fatty acid oxidation Julie Marcotorchino, Franck Tourniaire, Julien Astier, The Journal of Nutritional Biochemistry ObesityNutritionMetabolic SyndromeLipid NutritionPhysiology	2014	135
Vitamin D attenuates high fat diet–induced hepatic steatosis in rats by modulating lipid metabolism Yi Yin, Zhiwen Yu, Min Xia, European Journal of Clinical Investigation	2012	126
SREBP Activation by Antipsychotic- and Antidepressant-Drugs in Cultured Human Liver Cells: Relevance for Metabolic Side-Effects? Maria B. Ræder, Johan Fernø, Audun Osland Vik‐Mo, Molecular and Cellular Biochemistry PsychiatryMedicineLiver PhysiologyPsychotropic MedicationPsychopharmacology	2006	107
Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects? Stéphanie Le Hellard, Frank Theisen, Michael Haberhausen, Molecular Psychiatry ObesityMetabolic SyndromeBody CompositionMetabolic DisorderPsychiatry	2008	104

Page 1